Cost-effectiveness of ambroxol in the treatment of Gaucher disease type 2
Miloš N. Milosavljević,
Medo Gutić,
Vladimir Janjić
et al.
Abstract:Objective
Our aim was to compare the costs and efficacy of ambroxol in combination with imiglucerase with the costs and efficacy of imiglucerase only in the treatment of Gaucher disease type 2 (GD2) in the socio-economic settings of the Republic of Serbia, an upper-middle-income European economy.
Methods
The perspective of the Serbian Republic Health Insurance Fund was chosen for this study, and the time horizon was 6 years. … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.